FDA approves next-gen MicroPort CRM pacemakers

The Alizea pacemaker. [Image from MicroPort CRM]MicroPort CRM announced today that it received FDA approval for its Alizea and Celea implantable pacemakers.

The cardiac rhythm management subsidiary of MicroPort Scientific said its newly approved devices are the longest-lasting pacemakers for their size on the market today. They offer a volume of just 11cc and a projected longevity of 13 years.

Additionally, the company also received approval for the associated Vega pacing leads, SmartTouch XT tablet-based programmer and SmartView Connect Bluetooth home monitor.

MicroPort CRM said it marks a “significant achievement” for patient care. It also demonstrates the Clamart, France-based company’s commitment to the U.S. market.

“MicroPort CRM has always been committed to providing medical devices with the most advanced technology and features to improve patient outcomes and reduce the burden on the healthcare system”, said Benoît Clin…

Read more
  • 0

Medtech sales reach a record high as R&D spend and employee counts climb

The Medtech Big 100: The world’s largest medical device companies

The medtech industry is bouncing back from the economic fallout caused by the COVID-19 pandemic, according to an analysis of our Medtech Big 100 data.

The medical device industry has seemingly recovered from the economic headwinds caused by the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data from the Medtech Big 100, 100 of the largest medical device companies’ most recent annual results.

More than half of the companies listed in this year’s Big 100 ranking reported positive growth over their prior-year sales. Total revenue, research spending and employment figures were up significantly as the industry adjusts to a world with COVID-19 challenges.

For this analysis, we compared the performance of the Medtech Big 100 companies in 2021 and early 2022 with their results in 2020. Due to t…

Read more
  • 0